A Review of Von Hippel-Lindau Syndrome
Journal of Kidney Cancer and VHL · 02.08.2017 · 4 (3) · 20-29
DOI: 10.15586/jkcvhl.2017.88 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Kidney Cancer and VHL, online erschienen am 02.08.2017. Verfasst von Neha Varshney und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Toledo Medical Center, Toledo, OH, USA. Die Arbeit wurde bisher 211-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Von Hippel-Lindau syndrome (VHL) is a familial neoplastic condition seen in approximately 1 in 36,000 live births. It is caused by germline mutations of the tumor suppressor gene VHL, located on the short arm of chromosome 3. While the majority of the affected individuals have a positive family history, up to 20% of cases arise from de novo mutations. VHL syndrome is characterized by the presence of benign and malignant tumors affecting the central nervous system, kidneys, adrenals, pancreas, and reproductive organs. Common manifestations include hemangioblastomas of the brain, spinal cord, and retina; pheochromocytoma and paraganglioma; renal cell carcinoma; pancreatic cysts and neuroendocrine tumors; and endolymphatic sac tumors. Diagnosis of VHL is prompted by clinical suspicion and confirmed by molecular testing. Management of VHL patients is complex and multidisciplinary. Routine genetic testing and surveillance using various diagnostic techniques are used to help monitor disease progression and implement treatment options. Despite recent advances in clinical diagnosis and management, life expectancy for VHL patients remains low at 40–52 years. This article provides an overview of the major clinical, histological, and radiological findings, as well as treatment modalities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, University of Toledo Medical Center, Toledo, OH, USA.
- Department of Radiology, University of Toledo Medical Center, Toledo, OH, USA.
- Department of Surgery, Providence Hospital and Medical Center, Southfield, MI, USA.
- Department of Surgery, University of Minneapolis, St Paul, MN, USA.
Zitieren
APA
Varshney, N., Kebede, A. A., Owusu-Dapaah, H., Lather, J., Kaushik, M., & Bhullar, J. S. (2017). A Review of Von Hippel-Lindau Syndrome. Journal of Kidney Cancer and VHL, 4(3), 20-29. https://doi.org/10.15586/jkcvhl.2017.88
Vancouver
Varshney N, Kebede AA, Owusu-Dapaah H, Lather J, Kaushik M, Bhullar JS. A Review of Von Hippel-Lindau Syndrome. Journal of Kidney Cancer and VHL. 2017;4(3):20-29. doi:10.15586/jkcvhl.2017.88
BibTeX
@article{Varshney2017,
author = {Varshney, Neha and Kebede, Amanuel A and Owusu-Dapaah, Harry and Lather, Jason and Kaushik, Manu and Bhullar, Jasneet S},
title = {A Review of Von Hippel-Lindau Syndrome},
journal = {Journal of Kidney Cancer and VHL},
year = {2017},
volume = {4},
number = {3},
pages = {20--29},
doi = {10.15586/jkcvhl.2017.88}
}
EUVIMED